|Socio-economic burden of rare diseases: a systematic review of cost of illness evidence|
A Angelis, D Tordrup, P Kanavos
Health Policy 119 (7), 964-979, 2015
|Droplet Microfluidics Platform for Highly Sensitive and Quantitative Detection of Malaria-Causing Plasmodium Parasites Based on Enzyme Activity Measurement|
S Juul, CJF Nielsen, R Labouriau, A Roy, C Tesauro, PW Jensen, ...
ACS nano 6 (12), 10676-10683, 2012
|Structure of nanoscale truncated octahedral DNA cages: variation of single-stranded linker regions and influence on assembly yields|
CLP Oliveira, S Juul, HL Jørgensen, B Knudsen, D Tordrup, F Oteri, ...
Acs Nano 4 (3), 1367-1376, 2010
|Orphan drug considerations in Health Technology Assessment in eight European countries|
D Tordrup, V Tzouma, P Kanavos
Rare Diseases and Orphan Drugs 1 (3), 2014
|Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented?|
International journal of technology assessment in health care 30 (1), 10-19, 2014
|Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30|
D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ...
The Lancet Global Health 7 (9), e1180-e1188, 2019
|Deciphering the structural properties that confer stability to a DNA nanocage|
M Falconi, F Oteri, G Chillemi, FF Andersen, D Tordrup, CLP Oliveira, ...
ACS nano 3 (7), 1813-1822, 2009
|Variant Plasmodium ovale isolated from a patient infected in Ghana|
D Tordrup, J Virenfeldt, FF Andersen, E Petersen
Malaria Journal 10 (1), 1-5, 2011
|Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology|
L Kasonde, D Tordrup, A Naheed, W Zeng, S Ahmed
BMC health services research 19 (1), 383, 2019
|Is the funding of public national health systems sustainable over the long term? Evidence from eight OECD countries|
A Angelis, D Tordrup, P Kanavos
Global Policy 8, 7-22, 2017
|Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey|
D Tordrup, A Angelis, P Kanavos
Applied health economics and health policy 11 (6), 639-652, 2013
|RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases|
D Taruscio, C Morciano, P Laricchiuta, P Mincarone, F Palazzo, CG Leo, ...
Orphanet journal of rare diseases 9 (1), 1-1, 2014
|Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials|
E Karyotaki, D Tordrup, C Buntrock, R Bertollini, P Cuijpers
Epidemiol Psychiatr Sci 26, 501-16, 2017
|Peptide inhibition of topoisomerase IB from Plasmodium falciparum|
A Roy, I D'Annessa, CJF Nielsen, D Tordrup, RR Laursen, BR Knudsen, ...
Molecular biology international 2011, 2011
|Health economic evidence gaps and methodological constraints in low back pain and neck pain: Results of the Research Agenda for Health Economic Evaluation (RAHEE) project|
JM van Dongen, J Ketheswaran, D Tordrup, R Ostelo, R Bertollini, ...
Best Practice & Research Clinical Rheumatology 30 (6), 981-993, 2016
|CLC Main Workbench|
B Knudsen, T Knudsen, M Flensborg, H Sandmann, M Heltzen, ...
|Priorities for health economic methodological research: results of an expert consultation|
D Tordrup, C Chouaid, P Cuijpers, W Dab, JM Van Dongen, J Espin, ...
International journal of technology assessment in health care 33 (6), 609-619, 2017
|Research agenda for health economic evaluation|
D Tordrup, R Bertollini
Background Document, WHO Europe, Brüssel, 2013
|Topoisomerase I deficiency results in chromosomal alterations in cervical cancer cells|
E Kjeldsen, D Tordrup, GM HÜBNER, BR Knudsen, FF Andersen
Anticancer research 30 (9), 3257-3265, 2010
|Availability of medical supplies during the 2010 Pakistan floods|
D Tordrup, W Ahmed, KS Bukhari, P Kanavos
The Lancet Global Health 1 (1), e13-e14, 2013